Last reviewed · How we verify

NCT06031701

Neuro-psychosocial Teleassistance for Neuromuscular Diseases

Completed NA Last updated 17 January 2024
What this trial tests

NA trial testing Neuro-psychosocial teleassistance program in Social Competence in 35 participants. Completed in 30 June 2023.

Timeline
2 November 2021
Primary endpoint
30 November 2022
30 June 2023

Quick facts

Lead sponsorUniversity of Deusto
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment35
Start date2 November 2021
Primary completion30 November 2022
Estimated completion30 June 2023
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Deusto

Who can join

Adults 7 to 16, any sex, with Social Competence or Self Esteem. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a clinical trial to assess the effect of a neuropsychosocial intervention by means of telecare aimed at children and adolescents aged 7-16 years with neuromuscular diseases. The intervention is carried out in groups of 5 participants and is organised in 12 sessions: 1 session per week of 1h duration. The intervention is aimed at strengthening aspects of social cognition, self-esteem, social skills and aims at a reduction of symptomatology and a general improvement of psychological well-being.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Social Competence

Currently open trials in the same condition.

Other University of Deusto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06031701.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing